Connor, Clark & Lunn Investment Management (CC&L)’s IDEAYA Biosciences IDYA Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.91M	Buy	177,272 +128,352	+262%	+$4.31M	0.01%	636
2025 Q4	$1.69M	Buy	+48,920	New	+$1.56M	﹤0.01%	963
2024 Q4	–	Sell	-50,370	Closed	-$1.6M	–	1502
2024 Q3	$1.6M	Sell	50,370 -30,947	-38%	-$1.17M	0.01%	726
2024 Q2	$2.86M	Buy	81,317 +21,831	+37%	+$865K	0.01%	563
2024 Q1	$2.61M	Buy	+59,486	New	+$2.56M	0.01%	605
2023 Q3	–	Sell	-9,417	Closed	-$221K	–	1435
2023 Q2	$221K	Buy	+9,417	New	+$194K	﹤0.01%	1173

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s IDYA Position: Q1 2026 in Review

Connor, Clark & Lunn Investment Management (CC&L) increased its IDEAYA Biosciences (IDYA) stake by 262% in Q1 2026, buying an estimated $4.31M and bringing the position to 177,272 shares worth $5.91M. The position accounts for 0.01% of the portfolio, ranked #636.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in IDYA in Q2 2023 and has held it in 6 quarters since. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

Connor, Clark & Lunn Investment Management (CC&L) held 177,272 shares of IDEAYA Biosciences worth $5.91M as of Q1 2026.
Connor, Clark & Lunn Investment Management (CC&L) bought 128,352 IDEAYA Biosciences shares in Q1 2026, an estimated $4.31M.
IDEAYA Biosciences made up 0.01% of Connor, Clark & Lunn Investment Management (CC&L)'s portfolio in Q1 2026, its #636 holding.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in IDEAYA Biosciences in Q2 2023 and has held it in 6 quarters since.
253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2026, filed 11 May 2026.